CalciMedica, Inc. Research And Development Expense

• CalciMedica, Inc. showed an increase of +5.2% in Research And Development Expense from 2024 to 2025.
• This data is from CalciMedica, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), CalciMedica, Inc.'s Research And Development Expense has declined by 50.2%.
• Historical annual values: Fiscal year 2025: $15.23 million | Fiscal year 2024: $14.48 million | Fiscal year 2023: $15.86 million | Fiscal year 2022: $8.35 million | Fiscal year 2021: $18.90 million | Fiscal year 2020: $20.96 million | Fiscal year 2019: $30.58 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026